SugarBEAT®

Improve blood sugar management

Move beyond HbA1c

Nemaura Medical is a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) designed to provide persons with diabetes and pre-diabetics with an Ambulatory Glucose Profile (AGP) as a superior metric to better manage their glucose levels as compared to an HbA1c reading. Insulin users can adjunctively use sugarBEAT® when calibrated with a finger-stick glucose reading.

Addressing a global pandemic

With over 420 million diabetics worldwide and the number of pre-diabetics at almost three times this number, diabetes is a global healthcare concern.

Combining clinical research with patient-friendly technology, sugarBEAT® is expected to deliver a non-invasive, affordable and flexible method of tracking blood glucose for better diabetes management.

SugarBEAT® consists of a daily disposable adhesive skin-patch connected to a rechargeable transmitter, with an app displaying glucose readings every five minutes for periods up to 24 hours.

SugarBEAT® is expected to help person with diabetes and pre-diabetics better track how lifestyle factors can impact daily glucose level trends (known as an Ambulatory Glucose Profile) thereby significantly improving the amount of daily time spent in range.

This behavioural change in turn should help delay or even prevent long term health damage typically caused by diabetes.

How it works

Passing a mild, non-perceptible electric current across the skin, sugarBEAT® painlessly draws a small amount of glucose molecules out of the interstitial fluid which naturally sits just below the top layer of skin, into a chamber within the patch.

The rechargeable transmitter then measures the glucose levels present within the chamber, and securely transmits this clinically relevant data every five minutes via Bluetooth to a pre-downloaded smart phone / device app.

Using a proprietary algorithm, the app then converts this data into glucose values. In order to better understand how glucose levels are affected by lifestyle factors, diet / medication / exercise / mood data can also be inputted into the app.




Key Points

  • - SugarBEAT® market launch due 2018 initially in United Kingdom, followed shortly thereafter by key European countries
  • - SugarBEAT® daily price expected to be comparable to cost of using glucose meters and strips
  • - SugarBEAT's® 24 hour patch wear time allows for greater flexibility, with users able to wear on a non-consecutive day basis, unlike other glucose monitors which are designed to be continuously worn for 10-14 days
  • - SugarBEAT® expected to be non-invasive, painless and needle-free glucose trending device hence appeal to all persons with diabetes and pre-diabetics
  • - Each patch requires a 30-60 minute warm up, after which glucose readings are taken at five minute intervals for a period up to 24 hours
  • - SugarBEAT® can additionally be used by insulin using persons with diabetes as an adjunctive glucose monitoring device when calibrated by a finger stick reading
  • - For more information, please visit the sugarBEAT® website by clicking here

Stay informed

  • This field is for validation purposes and should be left unchanged.